| Janssen-Cilag AG - Balversa 5 mg, Filmtabletten | | 67660 | | 03 | | Balversa 5 mg | | Filmtabletten | | L01EN01 | | | | 14.01.2025 | | |
| | Composition | | erdafitinibum 5 mg, mannitolum, cellulosum microcristallinum, megluminum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, talcum, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), glyceroli monocaprylocapras, natrii laurilsulfas, pro compresso obducto corresp. natrium 0.55 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Erdafitinibum | 5 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Glyceroli Monocaprylocapras | | | | Magnesii Stearas | | | | Mannitol | | | | Meglumine | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 28 | DDP | DDP | A | | Non |
|
|
